Natixis’s CME Group CME Stock Holding History

Natixis’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-65,000	Closed	-$10.9M	–	1019
2022 Q4	$10.9M	Buy	+65,000	New	+$11.3M	0.06%	257

Other funds holding CME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Natixis's CME Position: Q1 2026 in Review

Natixis reduced its CME Group (CME) stake by 95% in Q1 2026, selling an estimated $33.3M and leaving 6,068 shares worth $1.79M. The position accounts for 0.01% of the portfolio, ranked #590.

Natixis first reported a position in CME in Q2 2013 and has held it in 44 quarters since. The position peaked at $70.5M in Q3 2019. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Natixis held 6,068 shares of CME Group worth $1.79M as of Q1 2026.
Natixis sold 112,268 CME Group shares in Q1 2026, an estimated $33.3M.
CME Group made up 0.01% of Natixis's portfolio in Q1 2026, its #590 holding.
Natixis first reported a position in CME Group in Q2 2013 and has held it in 44 quarters since.
Natixis's CME Group position peaked at $70.5M in Q3 2019.
1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.